Ocriplasmin: A Promising New Treatment for Vitreomacular Adhesion and Associated Retinal Disorders

Ocriplasmin: A Promising New Treatment for Vitreomacular Adhesion and Associated Retinal Disorders

Vitreomacular adhesion (VMA) is an identifiable consequence of incomplete …

Expiration Date: 8/1/2013

Max Credits: 0

View Activity

Pharmacokinetics of Intraocular Anti-VEGF Drugs

Pharmacokinetics of Intraocular Anti-VEGF Drugs

Most vascular endothelial growth factor (VEGF) mediated biological activit…

Expiration Date: 3/11/2015

Max Credits: 0

View Activity

New Diabetic Macular Edema Treatment Paradigm

New Diabetic Macular Edema Treatment Paradigm

Diabetic macular edema (DME) is a primary cause of vision loss in the work…

Expiration Date: 9/1/2013

Max Credits: 0

View Activity